Florence Tremollieres

Summary

Country: France

Publications

  1. ncbi request reprint [Screening techniques]
    Florence Tremollieres
    Unité ménopause et maladies osseuses métaboliques, Service d endocrinologie, CHU Rangueil, 31403 Toulouse
    Presse Med 31:694-8. 2002
  2. doi request reprint Impact of oral contraceptive on bone metabolism
    Florence Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, TSA 70034, 330 avenue de Grande Bretagne, 31059 Toulouse Cedex 9, France
    Best Pract Res Clin Endocrinol Metab 27:47-53. 2013
  3. doi request reprint [What patients need to know about the risk of bone fracture and its prevention]
    F Tremollieres
    Centre de ménopause et maladies osseuses métaboliques, Hôpital Paule de Viguier, 330 avenue de Grande Bretagne, Toulouse Cedex 9, France
    J Gynecol Obstet Biol Reprod (Paris) 41:F20-7. 2012
  4. doi request reprint [Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol?]
    F Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, TSA 70034, 31059 Toulouse Cedex 9, France
    Gynecol Obstet Fertil 40:109-15. 2012
  5. doi request reprint [How to prevent early postmenopausal fracture risk? Proposition of a strategy]
    F Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, CHU de Toulouse, Toulouse, France
    Gynecol Obstet Fertil 37:50-6. 2009
  6. doi request reprint Bone mineral density and prediction of non-osteoporotic disease
    Florence Tremollieres
    Menopause Center, Hôpital Paule de Viguier, TSA 70034, 330 avenue de Grande Bretagne, 31059 Toulouse, France
    Maturitas 65:348-51. 2010
  7. pmc Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool
    Florence A Trémollieres
    Menopause Center, Hôpital Paule de Viguier, Toulouse, France
    J Bone Miner Res 25:1002-9. 2010
  8. doi request reprint [Connective tissue and prolapse genesis]
    F Tremollieres
    MCU PH en médecine et biologie du développement et de la reproduction, Centre de ménopause, Hôpital Paule de Viguier, Toulouse, France
    Gynecol Obstet Fertil 38:388-93. 2010
  9. doi request reprint Fracture risk in early postmenopausal women assessed using FRAX
    Florence Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, TSA 70034, 31059 Toulouse Cedex 9, France
    Joint Bone Spine 77:345-8. 2010
  10. doi request reprint EMAS position statement: Managing menopausal women with a personal or family history of VTE
    Florence Tremollieres
    Florence Tremollieres Menopause and Metabolic Bone Disease Unit, Hôpital Paule de Viguier, Toulouse, France
    Maturitas 69:195-8. 2011

Detail Information

Publications24

  1. ncbi request reprint [Screening techniques]
    Florence Tremollieres
    Unité ménopause et maladies osseuses métaboliques, Service d endocrinologie, CHU Rangueil, 31403 Toulouse
    Presse Med 31:694-8. 2002
    ..Combined with densitometric measurements, they may permit the assessment of the level of bone remodeling and hence estimate bone loss, which is one of the determinant factors of fracture risk...
  2. doi request reprint Impact of oral contraceptive on bone metabolism
    Florence Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, TSA 70034, 330 avenue de Grande Bretagne, 31059 Toulouse Cedex 9, France
    Best Pract Res Clin Endocrinol Metab 27:47-53. 2013
    ..Whether this bone impact is also dependent on the dose of ethinyl-estradiol has not been fully elucidated. To date epidemiological studies did not report association between use of combined oral contraceptive and the risk of fracture...
  3. doi request reprint [What patients need to know about the risk of bone fracture and its prevention]
    F Tremollieres
    Centre de ménopause et maladies osseuses métaboliques, Hôpital Paule de Viguier, 330 avenue de Grande Bretagne, Toulouse Cedex 9, France
    J Gynecol Obstet Biol Reprod (Paris) 41:F20-7. 2012
    ..In addition, it is mostly beyond this age that the question of the prevention of hip fracture has to be considered...
  4. doi request reprint [Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol?]
    F Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, TSA 70034, 31059 Toulouse Cedex 9, France
    Gynecol Obstet Fertil 40:109-15. 2012
    ....
  5. doi request reprint [How to prevent early postmenopausal fracture risk? Proposition of a strategy]
    F Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, CHU de Toulouse, Toulouse, France
    Gynecol Obstet Fertil 37:50-6. 2009
    ..Use of bisphosphonate or strontium ranelate should be thus reserved at a more advanced age, when the prevention of hip fracture becomes mandatory...
  6. doi request reprint Bone mineral density and prediction of non-osteoporotic disease
    Florence Tremollieres
    Menopause Center, Hôpital Paule de Viguier, TSA 70034, 330 avenue de Grande Bretagne, 31059 Toulouse, France
    Maturitas 65:348-51. 2010
    ..Interestingly, all of these factors are modulated by estrogens. It could thus be hypothesized that the intensity of postmenopausal estrogen deficiency could be also the common pathogenic factor between atherosclerosis and osteoporosis...
  7. pmc Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool
    Florence A Trémollieres
    Menopause Center, Hôpital Paule de Viguier, Toulouse, France
    J Bone Miner Res 25:1002-9. 2010
    ..In this population, the FRAX tool, like other risk scores combining CRFs to either BMD or FRAX, had a poor sensitivity for fracture prediction and did not significantly improve the discriminatory value of hip BMD alone...
  8. doi request reprint [Connective tissue and prolapse genesis]
    F Tremollieres
    MCU PH en médecine et biologie du développement et de la reproduction, Centre de ménopause, Hôpital Paule de Viguier, Toulouse, France
    Gynecol Obstet Fertil 38:388-93. 2010
    ..The better understanding of the underlying determinants of pelvic floor disorders with a special focus on genetic factors may offer new therapeutic strategies, in addition to or replacement of surgical procedures...
  9. doi request reprint Fracture risk in early postmenopausal women assessed using FRAX
    Florence Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, TSA 70034, 31059 Toulouse Cedex 9, France
    Joint Bone Spine 77:345-8. 2010
    ..To evaluate FRAX 10-year fracture probabilities depending on the recommended management strategy in early postmenopausal women who were untreated at baseline...
  10. doi request reprint EMAS position statement: Managing menopausal women with a personal or family history of VTE
    Florence Tremollieres
    Florence Tremollieres Menopause and Metabolic Bone Disease Unit, Hôpital Paule de Viguier, Toulouse, France
    Maturitas 69:195-8. 2011
    ..Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is a serious cardiovascular event whose incidence rises with increasing age...
  11. doi request reprint Bone mineral density at menopause does not predict breast cancer incidence
    F A Tremollieres
    Unité Ménopause et Maladies Osseuses et Métaboliques, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, TSA 70034, 31059, Toulouse Cedex 9, France
    Osteoporos Int 19:1497-504. 2008
    ..1-year period of time, we observed no association between bone mineral density measured at the beginning of menopause and the subsequent risk of breast cancer...
  12. ncbi request reprint Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women
    F A Tremollieres
    Menopause and Bone Metabolic Diseases Unit, Endocrinology Department, CHU Rangueil, 1, avenue Jean Poulhes, F 31403 Toulouse, France
    Osteoporos Int 12:385-90. 2001
    ..The issue of assessing their risk of fracture several years after cessation of treatment thus needs to be addressed...
  13. ncbi request reprint [Raloxifene in postmenopausal women]
    F Tremollieres
    UF Ménopause et Maladies Osseuses Métaboliques, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, 31059 Toulouse cedex 09, France
    Gynecol Obstet Fertil 34:147-53. 2006
    ..Also, its lack of reimbursement in women with no prior fragility fracture must be taken into account...
  14. ncbi request reprint [Effect of hormonal contraception on bone mineral density]
    F Tremollieres
    Centre de ménopause, Hôpital Paule de Viguier, 330, avenue de Grande Bretagne, 31059 Toulouse Cedex 9, France
    Gynecol Obstet Fertil 33:520-5. 2005
    ..The bone impact of progestin only pills that have a strong antigonadotrophinic activity is not currently evaluated although there is some concern about increased bone loss in case of oestrogen deficiency period of long duration...
  15. ncbi request reprint [Current therapeutic means]
    Florence Tremollieres
    Unité ménopause et maladies osseuses métaboliques, Service d endocrinologie, CHU Rangueil, 31403 Toulouse
    Presse Med 31:699-703. 2002
    ..e., those presenting a t-score < -2.5 and a prevalent fracture (particularly vertebral crushing), situation which is relatively rare at the onset of the menopause...
  16. ncbi request reprint Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women
    Florence A Trémollieres
    Menopause and Metabolic Bone Diseases Unit, Hôpital Paule de Viguier, Toulouse, France
    Menopause 11:323-30. 2004
    ..The aim of this study was to examine the association between carotid intima-media thickness (IMT) and coronary heart diseases (CHD) risk factors in a large population of peri- and postmenopausal women...
  17. ncbi request reprint [Specific estrogen receptor modulators (SERMs)]
    Florence Tremollieres
    Unité de ménopause et maladies osseuses métaboliques, Service d endocrinologie, CHU Rangueil, Toulouse 31
    Presse Med 31:1323-8. 2002
    ..Its safety on gynecological level privileges its use in all women exhibiting benign breast or uterine pathologies at the origin of poor tolerance to HRT...
  18. ncbi request reprint [Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk]
    Claude Ribot
    Unité ménopause et maladies osseuses métaboliques, Hôpital Paule de Viguier, Toulouse 31
    Presse Med 35:1557-63. 2006
    ....
  19. doi request reprint Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Francoise Lenfant
    INSERM U1048 I2MC, Faculte de Medecine, Université de Toulouse III et CHU de Toulouse, Toulouse, France
    Maturitas 68:165-73. 2011
    ..Finally, we will analyze the possibilities to uncouple some beneficial from other undesirable actions following the partial/selective activation of estrogen receptors...
  20. pmc From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause
    Jean Francois Arnal
    INSERM U1048 I2MC, Faculte de Medecine, Université de Toulouse et CHU de Toulouse, Toulouse, France
    Br J Pharmacol 165:57-66. 2012
    ..In the present review, we attempted to summarize recent advances provided by the in vivo molecular 'dissection' of ERα, allowing the uncoupling of some of its actions and potentially paving the way to optimized selective ER modulators...
  21. doi request reprint The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling
    Cyril Seillet
    INSERM, U, Toulouse, France
    Blood 119:454-64. 2012
    ..Our results uncover a previously unappreciated role for estrogens in regulating the innate functions of pDCs, which may account for sex-based differences in autoimmune and infectious diseases...
  22. ncbi request reprint Aromatase and regulation of bone remodeling
    Claude Ribot
    UF Ménopause et Maladies Osseuse Métaboliques, Hôpital Paule de Viguier, jean Poulhes, Beforecty, Toulouse, France
    Joint Bone Spine 73:37-42. 2006
    ..Therefore, aromatase activity is a major determinant of estrogen activity in postmenopausal women. Studies are beginning to shed light on the mechanisms by which aromatase activity influences bone remodeling...
  23. ncbi request reprint [Management of postmenopausal osteoporosis]
    Claude Ribot
    Unité de ménopause et maladies osseuses métaboliques, Hôpital Paule de Viguier, TSA 70034, 31059 Toulouse Cedex 9
    Rev Prat 55:393-400. 2005
    ....
  24. ncbi request reprint Estrogens in vascular biology and disease: where do we stand today?
    Jean Francois Arnal
    Department of Vascular Biology and Atherothrombosis, INSERM U858 I2MR, CHU Toulouse Rangueil, Toulouse, France
    Curr Opin Lipidol 18:554-60. 2007
    ..There is also evidence for a thrombogenic effect of oral estrogens. An understanding of the deleterious and beneficial effects of estrogens is thus required...